~~<i id='03375B7867'><strike id='03375B7867'><tt id='03375B7867'><pre id='03375B7867'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：leisure time 2025-10-02 13:04:09 - browse：61113

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Bird flu researchers hone in on Finland’s mink farms

leisure time

hotspot

Wikipedia

focus

entertainment

hotspot

Neurons(red)andastrocytes(green)derivedfromhumanneuralstemcellsgrowinginculture.StevenPollard/Wellco

WSS

Biogen’s boardroom scandal saddles CEO with first crisis

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Timeline: How the deadly wildfires took over Maui day by day

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Judge sides with young activists in first

Bird flu: Don't repeat Covid's 'health versus the economy' framing

focus

focus

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Arc Institute generative AI designs new CRISPR systems

Tori Bowie and the unacceptable rates of Black maternal death

Addiction experts warn against a second 'war on drugs'

Heart attack and stroke risk calculators need revising

Military medical care influenced by rank and race, new study finds

Medical records are filled with copy

Data integrity in scientific journals requires "effort" by publishers, institutions

Heart attack and stroke risk calculators need revising

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

hotspot

Illinois Supreme Court finds assault weapons ban constitutional

Megan Rapinoe shares emotional post following US Women's World Cup exit

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Montana youths win climate lawsuit against state for promoting fossil fuels

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Criminal prosecution for violating HIPAA: an emerging threat

Wikipedia

focus

entertainment

hotspot